A Phase 1 Study of ASN004 in Patients With Advanced Solid Tumors

Conditions:   Breast Cancer;   Breast Neoplasms;   Breast Adenocarcinoma;   Breast Cancer Recurrent;   Breast Cancer Metastatic;   Breast Cancer Invasive;   Non-small Cell Lung Cancer;   Non-small Cell Carcinoma;   Non-small Cell Lung Cancer Recurrent;   Non-Small Cell Squamous L ung Carcinoma;   Non-Small Cell Adenocarcinoma;   Non-small Cell Lung Cancer Metastatic;   Colorectal Cancer;   Colorectal Neoplasms;   Colorectal Carcinoma;   Colorectal Adenocarcinoma;   Colorectal Cancer Metastatic;   Colorectal (Colon or Rectal) Cancer;   Colon Cancer;   Colon Neoplasm;   Ovarian Cancer;   Ovarian Neoplasm;   Ovarian Cancer Recurrent;   Carcinoma, Ovarian Epithelial;   Carcinoma Ovary;   Carcinoma Colon;   Carcinoma Breast;   Carcinoma, Non-Small-Cell Lung Intervention:   Drug: ASN004 Sponsor:   Asana BioSciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials